Abdulraheem Yacoub

Trials

Studies that name Abdulraheem Yacoub as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:06 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07447817 · Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

  John Mascarenhas · recruiting · Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis · study chair
• Early Ph1
  NCT06414681 · Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined

  University of Kansas Medical Center · recruiting · Myelofibrosis，MF · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
  P01CA108671 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ronald Hoffman · fiscal years 2006 to 2026
  Named on NCT07447817